Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NSE - Delayed Quote INR

Marksans Pharma Limited (MARKSANS.NS)

216.03
-12.34
(-5.40%)
At close: April 25 at 3:30:03 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Mark B. Saldanha Non-Independent Executive Chairman & MD 68.86M -- 1972
Mr. Jitendra M. Sharma Chief Financial Officer -- -- 1969
Mr. Vishal Bhargava Director Operations -- -- 1970
Mr. Harshavardhan Panigrahi Company Secretary, Manager of Legal & Compliance Officer -- -- --
Ms. Sandra Saldanha Whole-Time Executive Non Independent Director 7.07M -- 1971
Mr. Varddhman Vikramaditya Jain Whole-Time Executive Non Independent Director 18.75M -- 1970
Mr. Sunil K. Rane Senior Vice President of QC -- -- 1969
Mr. David Mohammed Managing Director of Australia Operations -- -- --
Mr. Sathish Kumar Managing Director of UK Operations -- -- --
Mr. Anjani Kumar Chief Operating Officer of US Operations -- -- 1960

Marksans Pharma Limited

Grandeur
11th Floor Veera Desai Extension Road Oshiwara, Andheri (West)
Mumbai, 400053
India
91 22 4001 2000 https://marksanspharma.com
Sector: 
Healthcare
Full Time Employees: 
1,141

Description

Marksans Pharma Limited, together with its subsidiaries, engages in the research, manufacturing, marketing, and sale of pharmaceutical formulations in the United States, North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the pain management, upper respiratory, cardiovascular, central nervous system, anti-diabetic, gastrointestinal, analgesics, upper respiratory, ear care, skincare, anticancer, anti-ulcerative, anti-allergy, antiviral, dietary, cardiac, dermatology, antihistamines, anti-fungal, anti-viral, laxatives, and cold and cough therapeutic areas. It also produces a range of solid oral dosage forms, including tablets and hard gelatin capsules; soft gels; essential oils; ointments; and creams and liquids, as well as prescription drugs. The company provides its products to supermarkets, high street retailers, pharmacy chains, and wholesalers. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Corporate Governance

Marksans Pharma Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 28, 2025 at 10:59 AM UTC - June 2, 2025 at 12:00 PM UTC

Marksans Pharma Limited Earnings Date

Recent Events

September 17, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers